The Wall Street Journal reports that Boston's once-booming biotech sector has hit a sharp downturn, leaving newly minted Ph.D.s struggling to find work as venture funding dries up, lab space sits empty, and companies downsize or relocate amid rising costs and policy uncertainty. The Wall Street Journal reports: Boston's biotech sector, long a vital economic engine for one of America's wealthiest metro areas, is sputtering. A double whammy of cutbacks in venture capital and government funding have taken a toll, leading to layoffs and struggles for job seekers. For workers who thought they would easily launch into a well-paying science career, the downturn has been especially harsh. Massachusetts experienced a slight decline in its roughly 65,000 biotech research-and-development jobs in 2024 after years of mostly strong increases, including during the Covid-19 pandemic, according to federal data. The numbers indicate that job losses continued through at least June, while hiring remains sluggish. By the end of September, nearly 28% of greater Boston's laboratory space sat empty, according to the latest estimates from real-estate firm CBRE. "Every stage of the life cycle has been impacted by policy or regulatory uncertainty this year," said Kendalle Burlin O'Connell, chief executive of MassBio, an industry trade group. The impact has hit startups especially hard, she said. A continued downturn poses risks for a region where workers will put up with sky-high real-estate costs if they can land high-paying jobs. Massachusetts faces competition from other states and China, which are eager to peel away talent and investment. "There are states and countries chasing us every single day," Gov. Maura Healey said in an interview. In late October, the Democrat testified before the Massachusetts legislature in support of a $400 million "competitiveness agenda" that she is seeking to spur new investment and supplement research funding lost this year. Lawmakers are reviewing the bill, a House spokesman said.

Read more of this story at Slashdot.

An anonymous reader quotes a report from the New York Times: Since online genealogy services began operating, millions of people have sent them saliva samples in hopes of learning about their family roots and discovering far-flung relatives. These services also appeal to law enforcement authorities, who have used them to solve cold case murders and to investigate crimes like the 2022 killing of four University of Idaho students. Crime-scene DNA submitted to genealogy sites has helped investigators identify suspects and human remains by first identifying relatives. The use of public records and family-tree building is crucial to this technique, and its main tool has been the genealogy site Ancestry, which has vast amounts of individual DNA profiles and public records. More than 1,400 cases have been solved with the help of so-called genetic genealogy investigations, most of them with help from Ancestry. But a recent step taken by the site is now deterring many police agencies from employing this crime-solving technique. In August, Ancestry revised the terms and conditions on its site to make it clear that its services were off-limits "for law enforcement purposes" without a legal order or warrant, which can be hard to get, because of privacy concerns. This followed the addition last year to the terms and conditions that the services could not be used for "judicial proceedings." Investigators say the implications are dire and will result in crucial criminal cases slowing or stalling entirely, denying answers to grieving families. "Everyone who does this work has depended on the records database that Ancestry controls," said David Gurney, who runs Ramapo College's Investigative Genetic Genealogy Center in New Jersey. "Without it, casework is going to be a lot slower, and there will be some cases that can't be resolved at all."

Read more of this story at Slashdot.